The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2024 Jan 3

PMID 38169634

Authors

Yimeng Shu

Guoqing Huang

Yushan Mao

Affiliations

Soon will be listed here.

Abstract

Purpose: Hyperuricemia (HUA) is a recognized risk factor for non-alcoholic fatty liver disease (NAFLD). Early diagnosis and the identification of predictive factors are important for the HUA population. This study aimed to investigate the potential relationship between the metabolic score for insulin resistance (METS-IR) index and the triglyceride and glucose (TyG) index with NAFLD in individuals with HUA.

Patients And Methods: A total of 5537 HUA participants were included in the study. Hepatic ultrasonography was conducted following the latest diagnostic criteria to diagnose NAFLD. The relationship between the TyG and METS-IR index and NAFLD was evaluated by multivariable logistic regression analysis and restricted cubic spline model (RCS). In addition, the area under the curve (AUC), positive likelihood ratio, and negative likelihood ratio were explored to compare the predictive value of IR surrogates for NAFLD with HUA. The AUCs of the two indicators were compared using the DeLong test.

Results: Multivariable logistic regression analysis revealed that elevated TyG (OR = 2.285, 95% CI: 1.525, 3.428) and METS-IR (OR = 1.242, 95% CI: 1.219, 1.266) indices significantly increase the risk of NAFLD. Meanwhile, the RCS analysis revealed a -log-shaped nonlinear relationship between NAFLD risk and the METS-IR index ( < 0.001), contrasting with the linear association observed with the TyG index ( = 0.763). Notably, the risk of NAFLD demonstrated a significant escalation when the METS-IR index exceeded the threshold of 39.208 (OR=1). Compared to the TyG index (AUC = 0.734, 95% CI: 0.721~0.748), the METS-IR index (AUC = 0.821, 95% CI: 0.810~0.832) demonstrated superior predictive value for NAFLD in individuals with HUA according to the DeLong test.

Conclusion: In the HUA population, the METS-IR index has a higher predictive value for NAFLD than the TyG index, contributing to early diagnosis and disease prevention.

References

Smiderle C, Coral G, DE Carli L, de Mattos A, de Mattos A, Tovo C . PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS. Arq Gastroenterol. 2021; 58(2):139-144. DOI: 10.1590/S0004-2803.202100000-24. View

Duell P, Welty F, Miller M, Chait A, Hammond G, Ahmad Z . Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2022; 42(6):e168-e185. DOI: 10.1161/ATV.0000000000000153. View

Mazidi M, Katsiki N, Mikhailidis D, Banach M . The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis. 2018; 270:180-186. DOI: 10.1016/j.atherosclerosis.2017.12.033. View

Petrescu M, Vlaicu S, Ciumarnean L, Milaciu M, Marginean C, Florea M . Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue. Medicina (Kaunas). 2022; 58(5). PMC: 9147364. DOI: 10.3390/medicina58050641. View

Aktas G, Yilmaz S, Kantarci D, Duman T, Bilgin S, Balci S . Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury?. Postgrad Med. 2023; 135(5):519-523. DOI: 10.1080/00325481.2023.2214058. View

Kurtkulagi O, Atak Tel B, Kahveci G, Bilgin S, Duman T, Erturk A . Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021; 59(4):403-408. DOI: 10.2478/rjim-2021-0023. View

Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J . The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017; 16(1):15. PMC: 5248473. DOI: 10.1186/s12944-017-0409-6. View

Chalasani N, Younossi Z, Lavine J, Diehl A, Brunt E, Cusi K . The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55(6):2005-23. DOI: 10.1002/hep.25762. View

Wang J, Qin T, Chen J, Li Y, Wang L, Huang H . Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One. 2014; 9(12):e114259. PMC: 4250178. DOI: 10.1371/journal.pone.0114259. View

10.

Yen P, Chou Y, Li C, Sun Z, Wu C, Chang Y . Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It. J Clin Med. 2022; 11(5). PMC: 8911142. DOI: 10.3390/jcm11051445. View

11.

Aktas G, Kocak M, Bilgin S, Atak B, Duman T, Kurtkulagi O . Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2019; 23(5):1098-1102. DOI: 10.1080/13685538.2019.1678126. View

12.

Kocak M, Aktas G, Erkus E, Sincer I, Atak B, Duman T . Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019; 65(1):9-15. DOI: 10.1590/1806-9282.65.1.9. View

13.

Gastaldelli A . Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?. Clin Sci (Lond). 2017; 131(22):2701-2704. DOI: 10.1042/CS20170987. View

14.

Wang F, Fan J, Zhang Z, Gao B, Wang H . The global burden of liver disease: the major impact of China. Hepatology. 2014; 60(6):2099-108. PMC: 4867229. DOI: 10.1002/hep.27406. View

15.

Younossi Z, Tacke F, Arrese M, Sharma B, Mostafa I, Bugianesi E . Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2018; 69(6):2672-2682. DOI: 10.1002/hep.30251. View

16.

Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008; 6(4):299-304. DOI: 10.1089/met.2008.0034. View

17.

Chen Z, Qin H, Qiu S, Chen G, Chen Y . Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research. Lipids Health Dis. 2019; 18(1):162. PMC: 6689160. DOI: 10.1186/s12944-019-1104-6. View

18.

Widjaja N, Irawan R, Hanindita M, Ugrasena I, Handajani R . METS-IR vs. HOMA-AD and Metabolic Syndrome in Obese Adolescents. J Med Invest. 2023; 70(1.2):7-16. DOI: 10.2152/jmi.70.7. View

19.

Akin F, Altun I, Ayca B, Kose N, Altun I . Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults. Bosn J Basic Med Sci. 2022; 22(6):1025-1032. PMC: 9589308. DOI: 10.17305/bjbms.2022.7142. View

20.

Wan X, Xu C, Lin Y, Lu C, Li D, Sang J . Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2015; 64(4):925-32. DOI: 10.1016/j.jhep.2015.11.022. View